• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Public Health

New obesity framework may reclassify over half of overweight individuals as people with obesity

byAdrian WongandThomas Su
July 14, 2025
in Public Health
Reading Time: 3 mins read
Obesity measurement collage: a bathroom scale with a blank dial, a loose cloth measuring tape, an apple and a pear
Share on FacebookShare on TwitterShare on LinkedIn

1. In this cross-sectional study, a new obesity framework from the European Association for the Study of Obesity reclassified an additional nearly one-fifth of the United States population as obese.

2. The newly classified people with obesity had a higher mortality risk compared with adults with normal weight and no comorbidities, although they had similar risk to adults with normal weight and comorbidities.

Evidence Rating Level: 3 (Average)

Study Rundown: The European Association for the Study of Obesity (EASO) recently released a new framework defining obesity either as body mass index (BMI) ≥30 kg/m2 or as BMI between 25 and 30 kg/m2 with an elevated waist-to-height ratio (WtHR) and the presence of any medical, functional, or psychological complications. This study aimed to compare the population of individuals with obesity according to the existing definition and the EASO definition, and examine the complications prevalent within the newly defined subset. Among a sample of American adults, over one-third of the population was considered PWO per BMI alone; the new definition led to almost an additional twenty percent of the population being reclassified as PWO. Of the one-third of individuals who were considered overweight by BMI alone, over half were PWO; these individuals were generally older compared to those who were considered overweight or PWO per BMI alone. The newly classified PWO were more likely to have comorbidities, with the most common being hypertension and arthritis. Among patients considered overweight who were not reclassified as PWO, the majority met the WtHR ratio but did not meet the morbidity requirement. The newly reclassified PWO had a higher mortality compared with individuals with normal weight and no comorbidities, but similar mortality to that of individuals with normal weight who had comorbidities. The generalizability of this study was limited by potential confounding, the cross-sectional design, and missing data. Overall, this study clarified how the new EASO framework affected the apparent population makeup of PWO.

Click to read the study in AIM

Relevant Reading: A new framework for the diagnosis, staging and management of obesity in adults

RELATED REPORTS

Increased alcohol consumption among post-menopausal women is associated with higher mortality

2 Minute Medicine Rewind October 26, 2026

FDA approvedFor obesity: Foundayo (orforglipron), Apr 1, 2026→

In-Depth [cross-sectional study]: This study aimed to determine how the new EASO framework affected the population distribution of individuals with overweight and obesity. The patient population was sampled from the National Health and Nutrition Examination Survey (NHANES), made up of individuals aged between 18 and 79 years.  The EASO framework defined normal as BMI between 18.5 and 25 kg/m2, overweight as BMI between 25 and 30 kg/m2 with WtHR <0.5 or without comorbidities, and obesity as BMI ≥30 kg/m2 or between 25 and 30 kg/m2 with WtHR ≥0.5 and at least 1 comorbidity. After applying exclusion criteria, the final sample was 44,030 individuals. Based on BMI alone, 31.3% of the study population was considered normal weight, 33.3% overweight, and 35.4% PWO. Applying the EASO framework caused 18.8% of participants (56.4% of people with overweight) to be reclassified as PWO, meaning that 54.2% of participants were now considered PWO. More men (21.9%) than women (15.6%) were newly classified as PWO; the newly classified PWO were older (51.3 years; standard deviation [SD], 14.5) than persons defined as overweight (36.5 years; SD, 12.2) or PWO (45.4 years; SD, 15.0) based on BMI alone. Among the newly classified PWO, 57.5% had at least 1 comorbidity and 42.5% had more than 1, compared with 34.3% and 38.7%, respectively, among PWO based on BMI alone. Compared with individuals with normal weight and no comorbidities, both the newly classified PWO (adjusted HR, 1.50 [95% CI, 1.20 to 1.88]) and individuals with BMI ≥30 kg/m2 (adjusted HR, 1.82 [95% CI, 1.46 to 2.27]) had higher mortality risk, which was not significantly different from the mortality risk among individuals with normal weight and comorbidities (HR, 1.74 [95% CI, 1.34 to 2.22]). Both the newly classified PWO (adjusted HR, 1.77 [95% CI, 1.36 to 2.32]) and individuals with BMI ≥30 kg/m2 (adjusted HR, 1.76 [95% CI, 1.36 to 2.29]) had increased mortality risk compared with individuals who remained classified as overweight. These effects were consistent across subgroup analyses.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: body mass index (BMI)mortalityobesityoverweightwaist circumferencewaist-to-hip ratio
Previous Post

Digital health apps may have limited role in reduction of migraine symptoms

Next Post

2 Minute Medicine Rewind July 14, 2025

RelatedReports

A woman gently holding her shoulder, reflecting a contemplative mood, with art elements representing healing and growth around her.
Chronic Disease

Increased alcohol consumption among post-menopausal women is associated with higher mortality

October 28, 2026
An abstract representation of therapeutic pathways and personal journeys towards mental health improvement, with visual elements suggesting anxiety or panic states.
Weekly Rewinds

2 Minute Medicine Rewind October 26, 2026

October 27, 2026
Collage of torn-gray map pieces with orange route from left to a doorway on the right, over a dark backdrop; scales of justice at top; '2 Minute Medicine' logo in bottom right.
Obstetrics

Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy

October 21, 2026
A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.
Chronic Disease

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

October 7, 2026
Next Post
Ischemic stroke collage: an engraved brain with one artery traced in blue beside a glass hourglass on graph paper

2 Minute Medicine Rewind July 14, 2025

#VisualAbstract: Brain Activation Measured on Functional MRI Predicts Response to Certolizumab, a TNF Inhibitor, in Rheumatoid Arthritis

#VisualAbstract: Brain Activation Measured on Functional MRI Predicts Response to Certolizumab, a TNF Inhibitor, in Rheumatoid Arthritis

Brain health collage: an engraved brain in side view, a branching neuron, a plain brain-slice silhouette and a reflex hammer

Type 2 diabetes and abnormal amyloid concentrations are associated with accelerated brain atrophy

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Docosahexaenoic acid supplementation does not reduce risk of necrotizing enterocolitis among preterm infants
  • AI-drafted responses to patient messages linked to faster reply times but no drop in after-hours work for clinicians
  • FDA identifies safety concerns for compounded peptide injections, including reports of death
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.